Economic and Business Impact of the Spread of COVID-19
First written in FY2020. 6 of 13 entries say "Reframed", first in FY2021. Latest entry: FY2026.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2026ReframedAnnual report
「In addition, if a new infectious disease or other illness spreads and business activities are disrupted by employee infections, delays in procuring raw materials, or production stoppages, or if demand for the Group's products declines because customers or business partners suspend operations or revise production plans, this may affect the Group's financial condition and operating results.」
The risk description has been reorganized from one specific to COVID-19 to cover infectious disease risks, including new infectious diseases, delays in procuring raw materials, production stoppages, and customers and business partners revising production plans. - FY2024ReframedAnnual report
「In addition, if COVID-19 or a new infectious disease spreads, this may affect the Group's financial condition and operating results through employee infections, delays in procuring raw materials, production stoppages, or a decline in demand for the Group's products caused by customers or business partners suspending operations or revising production plans.」
The risks are organized to include the spread of new infectious diseases in addition to COVID-19, delays in procuring raw materials, production stoppages, and customers and business partners revising their plans. - FY2024-Q2ReframedAnnual report
「During the first six months of the fiscal year, Japan's domestic economy saw the full-scale resumption of economic activity as restrictions on movement related to COVID-19 were eased. However, uncertainty about the outlook continued amid concerns about an economic slowdown against a backdrop of monetary tightening led by Europe and the United States, rapid yen depreciation and geopolitical risks resulting from an unstable international situation.」
The easing of COVID-19-related restrictions on movement and the full resumption of economic activity have been indicated, while the focus of uncertainty has shifted from the pandemic's impact to monetary tightening, a weaker yen, and geopolitical risks. - FY2024-Q1ReframedAnnual report
「During the first three months of the fiscal year, Japan's domestic economy progressed toward normalization of economic activity as restrictions on movement related to COVID-19 were largely eased. However, uncertainty about the outlook continued amid concerns about an economic slowdown against a backdrop of global monetary tightening, rapid yen depreciation and persistently high raw material prices.」
While restrictions on movement related to COVID-19 have been eased and economic activity has been returning to normal, factors creating uncertainty about the outlook, including monetary tightening, a weaker yen, and persistently high raw material prices, have come to the fore. - FY2023ReframedAnnual report
「Although the impact of COVID-19 on the Group's results during the current consolidated fiscal year was limited, if the pandemic does not move toward containment in Japan and other major countries, continues to spread for an extended period, resurges after being contained, or another infectious disease spreads, and employees or officers of the Group or its business partners become infected, or if the Group's business activities decline significantly due to deteriorating market conditions caused by an economic slowdown or production stoppages at domestic or overseas customers, this may affect its financial condition and operating results.」
While the impact on results for the current fiscal year was considered limited, future risks from a resurgence of infections, other infectious diseases, and customers suspending production continue. - FY2022-Q3WorsenedAnnual report
「During the first nine months of the current fiscal year, the Japanese economy continued to face restrictions resulting from the impact of COVID-19, while higher vaccination rates raised expectations for a normalization of economic activity. However, the emergence of the Omicron variant has not eliminated the risk of another surge in infections, and the outlook remains uncertain.」
While higher vaccination rates have raised expectations for a return to normal activity, the emergence of the Omicron variant has not eliminated the risk of another surge in infections, and uncertainty about the outlook continues. - FY2022-Q2RestatedAnnual report
「There have been no material changes to the assumptions, including the expected timing of the end of the COVID-19 pandemic, described in the additional information section of the previous consolidated fiscal year’s annual securities report under “Accounting estimates affected by the spread of COVID-19.”」
The company states that there have been no material changes from the previous fiscal year to the assumptions underlying accounting estimates, including the expected timing of the end of the COVID-19 pandemic. - FY2022-Q1RestatedAnnual report
「There have been no material changes to the assumptions, including the expected timing of the end of the COVID-19 pandemic, described in the additional information section of the previous consolidated fiscal year’s annual securities report under “Accounting estimates affected by the spread of COVID-19.”」
The company states that there have been no material changes from the previous fiscal year to the assumptions underlying accounting estimates, including the expected timing of the end of the COVID-19 pandemic. - FY2021ReframedAnnual report
「The impact of COVID-19 on the Group's results during the current consolidated fiscal year was limited, although stagnation of business activity due to weaker market conditions was observed in some areas. However, amid the global resurgence of COVID-19, if deteriorating market conditions caused by an economic slowdown or production stoppages at domestic or overseas customers cause the Group's business activities to decline significantly, this may affect its financial condition and operating results.」
While the impact on results for the current fiscal year was considered limited, the risks of deteriorating market conditions and customers suspending production due to a resurgence of COVID-19 continue to be recognized. - FY2021-Q3WorsenedAnnual report
「During the first nine months of the fiscal year, Japan's domestic economy showed signs of a gradual recovery as economic activity resumed in stages following a period of stagnation caused by the spread of COVID-19. However, the spread of the infection has again become more serious recently, and uncertainty about the outlook continues.」
Although economic activity has resumed, the spread of COVID-19 has recently become more serious again, increasing uncertainty surrounding the economic and business environment associated with the pandemic. - FY2021-Q2MaterialisedAnnual report
「During the first nine months of the current fiscal year, the semiconductor and LCD segment remained firm, but sales declined to ¥16,612 million, down 3.1% year on year, because shipments of some products decreased due to the stagnation of the automotive industry and other factors resulting from the spread of COVID-19.」
The stagnation of the automotive industry and other factors resulting from the spread of COVID-19 are described as having affected actual results through lower shipments of some products and a 3.1% year-on-year decline in consolidated sales. - FY2021-Q1RestatedAnnual report
「There have been no material changes to the assumptions, including the expected timing of the end of the COVID-19 pandemic, described in the additional information section of the previous consolidated fiscal year’s annual securities report under “Accounting estimates affected by the spread of COVID-19.”」
The company states that there have been no material changes from the previous fiscal year to the assumptions underlying accounting estimates, including the expected timing of the end of the COVID-19 pandemic. - FY2020First statedAnnual report
「If the spread of COVID-19 causes demand for the Group's products to decline as market conditions weaken, or results in situations such as domestic or overseas business partners suspending production, this may affect the Group's financial condition and operating results.」
For the first time, the risks of declining demand, business partners suspending production, and operational suspensions caused by employee infections due to a global pandemic are described as a standalone item. While some customers have already been affected by lower operating rates or production stoppages, the impact on the Group's own sites as of the fiscal year-end is described as limited.